Allelic distribution and the effect of haplotype combination for HLA type II loci in the celiac disease population of the Valencian community (Spain)

Tissue Antigens

Volumn 73, Issue 3, 2009, Pages 255-261

  Donat, E ^a   Planelles, D ^b   Capilla Villanueva, A ^a   Montoro, J A ^b   Palau, F ^c   Ribes Koninckx, C ^a  

^a HOSPITAL INFANTIL LA FE   (Spain)

^b Ctro Transfus Comunidad Valenciana   (Spain)

^c INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

Celiac disease; Comunidad Valenciana; HLA DQ2 heterodimer; Synergistic effect

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ2 ANTIGEN; HLA DQA1 ANTIGEN; HLA DR ANTIGEN; HLA DR11 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR7 ANTIGEN;

ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE DOSAGE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; POPULATION; PRIORITY JOURNAL; RISK FACTOR; SPAIN;

ALLELES; CELIAC DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HLA-D ANTIGENS; HUMANS; POPULATION GROUPS; SPAIN;

EID: 60749100423     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01191.x     Document Type: Article

References (40)

1. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000 : 18 : 53 81.
2. Petronzelli F, Bonamico M, Ferrante P et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997 : 61 : 307 17.
3. Bevan S, Popat S, Braegger CP et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 1999 : 36 : 687 90.
4. Sollid LM, Thosby E. HLA susceptibility genes in celiac disease: genetic mapping and role in the pathogenesis. Gastroenterology 1993 : 105 : 910 22.
5. McCluskey J, Peh CA. The human leucocyte antigens and clinical medicine: an overview. Rev Immunogenetics 1999 : 1 : 3 20.
6. Walker-Smith JA, Guandalini S, Schmitz J, Shmerling DH, Visakorpi JK. Revised criteria for diagnosis of coeliac disease. Report of working group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990 : 65 : 909 11.
7. Olerup O, Zetterquist H. HLA DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992 : 39 : 225 35.
8. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993 : 41 : 119 34.
9. Kawasaki ES. Sample preparation from blood, cells, and other fluids. In : Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. pCR Protocols: A Guide to Methods and Applications. New York : Academic Press, 1990, 146.
10. Tiwari JL, Terasaki PI. The data and statistical analysis. In : Tiwari JL, Terasaki PI, eds. HLA and Disease Associations. New York : Springer-Verlag, 1985, 18 27.
11. Woolf B. On estimating the relationship between blood group and disease. Ann Hum Genet 1995 : 19 : 251 3.
12. Hu CHY, Allen M, Chuang LM, Lin BJ, Gyllensten U. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum Immunol 1993 : 38 : 105 14.
13. Duquesnoy RJ, Tranetzki MS. Determination of the probability of exclusion by the HLA system in cases of disputed parentage. In : Walker RH, ed. Inclusion Probabilities in Parentage Testing. Bethesda, MD : American Association of Blood Banks, 1983, 305.
14. Svejgaard A, Ryder LP. HLA and diseases associations: detecting he strongest association. Tissue Antigens 1994 : 43 : 18 27.
15. Spurkland A, Ingvarsson G, Falk E, Knutsen I, Sollid Lm, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated to the HLA- DQ (α1*0501,β1*02) or the HLA-DQ (α1*03, β1*0302) heterodimers. Tissue Antigens 1997 : 49 : 29 31.
16. Tighe MR, Hall MA, Barbado M, Cardi E, Welsh KI, Ciclitira PJ. HLA class II alleles associated with celiac disease susceptibility in a southern European population. Tissue Antigens 1992 : 40 : 90 7.
17. Congia M, Frau F, Lampis R et al. A high frequency of the A30, B18, DR3, DRw52, DQw2 extended haplotype in Sardinian celiac disease patients: further evidence that disease susceptibility is conferred by DQ A1*0501, B1*0201. Tissue Antigens 1992 : 39 : 78 83.
18. Michalski JP, McCombs CC, Arai T et al. DQ genotypes of celiac disease patients and healthy subjects from the West of Ireland. Tissue Antigens 1996 : 47 : 127 33.
19. Herrera M, Theiler G, Augustovski F et al. Molecular characterization of HLA class II genes in celiac disease patients of Latin American Caucasian origin. Tissue Antigens 1994 : 43 : 83 7.
20. Tighe MR, Hall MA, Ashkenazi A, Siegler E, Lanchbury JS, Ciclitira PJ. Celiac disease among Ashkenazi Jews from Israel. A study of the HLA class II alleles and their associations with disease susceptibility. Hum Immunol 1993 : 38 : 270 6.
21. Johnson TC, Diamond B, Memeo L et al. Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin Gastroenterol Hepatol 2004 : 2 : 888 94.
22. Perez-Bravo F, Araya M, Mondragon A et al. Genetic differences in HLA-DQA1* and DQB1* allelic distributions between celiac and control children in Santiago, Chile. Hum Immunol 1999 : 60 : 262 7.
23. Peña-Quintana L, Torres-Galvan MJ, Deniz-Naranjo MC et al. Assessment of the DQ heterodimer test in the diagnosis of celiac disease in the Canary Islands (Spain). J Pediatr Gastroenterol Nutr 2003 : 37 : 604 8.
24. Undlien DE, Kockum I, Ronningen KS et al. HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes. Tissue Antigens 1999 : 54 : 543 51.
25. Margaritte-Jeannin P, Babron MC, Bourgey M et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European genetics cluster on coeliac disease. Tissue Antigens 2004 : 63 : 562 7.
26. Mearin ML, Biemond I, Pena AS et al. HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut 1983 : 24 : 532 7.
27. Mearin ML, Bouquet J, Mourad N et al. HLA-DR antigens and phenotypes in Dutch coeliac children and their families. Clin Genet 1985 : 27 : 45 50.
28. Karell K, Louka AS, Moodie SJ et al. European genetics cluster on celiac disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European genetics cluster on celiac disease. Hum Immunol 2003 : 64 : 469 77.
29. Polvi A, Arranz E, Fernandez-Arquero M et al. HLA-DQ2-negative celiac disease in Finland and Spain. Hum Immunol 1998 : 59 : 169 75.
30. Karell K, Louka AS, Moodie SJ et al. European genetics cluster on celiac disease. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European genetics cluster on celiac disease. Hum Immunol 2003 : 64 : 469 77.
31. Bouguerra F, Babron MC, Eliaou JF et al. Synergistic effect of two HLA heterodimers in the susceptibility to celiac disease in Tunisia. Genet Epidemiol 1997 : 14 : 413 22.
32. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2005 : 129 : 1294 301.
33. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003 : 61 : 105 17.
34. Arranz E, Telleria JJ, Sanz A et al. HLA-DQA1*0501 and DQB1*02 homozygosity and disease susceptibility in Spanish coeliac patients. Exp Clin Immunogenet 1997 : 14 : 286 90.
35. Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993 : 41 : 173 7.
36. Louka AS, Nilsson S, Olsson M et al. HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried. Tissue Antigens 2002 : 60 : 147 54.
37. Hernandez-Charro B, Donat E, Miner I, Aranburu E, Sanchez Valverde F, Ramos-Arroyo M. Modifying effect of HLA haplotypes located trans to DQB1*02-DRB1*03 in celiac patients of Southern Europe. Tissue Antigens 2008 : 71 : 213 8.
38. Planelles D, Puig N, Beneto A et al. HLA-DQA, -DQB and -DRB allele contribution to narcolepsy susceptibility. Eur J Immunogenet 1997 : 24 : 409 21.
39. Kaukinen K, Partanen J, Maki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002 : 97 : 695 9.
40. Sollid LM, Lie BA. Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 2005 : 3 : 843 51.